Literature DB >> 25150019

Anti-citrullinated heat shock protein 90 antibodies identified in bronchoalveolar lavage fluid are a marker of lung-specific immune responses.

Lisa Harlow1, Bernadette R Gochuico2, Ivan O Rosas3, Tracy J Doyle3, Juan C Osorio3, Timothy S Travers4, Carlos C Camacho4, Chester V Oddis5, Dana P Ascherman6.   

Abstract

Previous work has demonstrated a correlation between serum anti-citrullinated HSP90 antibodies and rheumatoid arthritis-associated interstitial lung disease (RA-ILD). To further investigate this potential pathogenic relationship, we used ELISA-based techniques to assess anti-citrullinated HSP90 antibody profiles in bronchoalveolar lavage fluid (BALF) of patients with different stages of RA-ILD. 9/21 RA-derived BALF specimens demonstrated IgG and/or IgA antibodies targeting citrullinated HSP90 proteins/peptides, highlighting disease specific responses (with a predilection for RA-ILD) that did not occur in IPF patients (0/5) or healthy control subjects (0/5). Comparison of antibody profiles between BALF and matching serum specimens revealed various recognition patterns favoring predominant production of anti-citrullinated HSP90 antibodies within the lung microenvironment-further supporting the connection between this antibody specificity and parenchymal lung disease. Equally important, qualitative as well as quantitative differences in anti-citrullinated HSP90 profiles between BALF and serum indicate that the lung plays a direct role in shaping the immune repertoire of RA/RA-ILD. Published by Elsevier Inc.

Entities:  

Keywords:  Autoantibodies; Bronchoalveolar lavage fluid; Citrullination; HSP90; Interstitial lung disease; Rheumatoid arthritis

Mesh:

Substances:

Year:  2014        PMID: 25150019      PMCID: PMC4629481          DOI: 10.1016/j.clim.2014.08.004

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  29 in total

1.  Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations.

Authors:  Cengiz Korkmaz; Tercan Us; Timuçin Kaşifoğlu; Yurdanur Akgün
Journal:  Clin Biochem       Date:  2006-07-13       Impact factor: 3.281

2.  Progressive preclinical interstitial lung disease in rheumatoid arthritis.

Authors:  Bernadette R Gochuico; Nilo A Avila; Catherine K Chow; Levi J Novero; Hai-Ping Wu; Ping Ren; Sandra D MacDonald; William D Travis; Mario P Stylianou; Ivan O Rosas
Journal:  Arch Intern Med       Date:  2008-01-28

3.  Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease.

Authors:  Thomas J Richards; Aaron Eggebeen; Kevin Gibson; Samuel Yousem; Carl Fuhrman; Bernadette R Gochuico; Noreen Fertig; Chester V Oddis; Naftali Kaminski; Ivan O Rosas; Dana P Ascherman
Journal:  Arthritis Rheum       Date:  2009-07

4.  Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study.

Authors:  Tim Bongartz; Carlotta Nannini; Yimy F Medina-Velasquez; Sara J Achenbach; Cynthia S Crowson; Jay H Ryu; Robert Vassallo; Sherine E Gabriel; Eric L Matteson
Journal:  Arthritis Rheum       Date:  2010-06

5.  IgM-type GM-CSF autoantibody is etiologically a bystander but associated with IgG-type autoantibody production in autoimmune pulmonary alveolar proteinosis.

Authors:  Takahito Nei; Shinya Urano; Natsuki Motoi; Jun Takizawa; Chinatsu Kaneko; Hiroko Kanazawa; Ryushi Tazawa; Kazuhide Nakagaki; Kiyoko S Akagawa; Keiichi Akasaka; Toshio Ichiwata; Arata Azuma; Koh Nakata
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-24       Impact factor: 5.464

Review 6.  Extra-articular manifestations and complications of rheumatoid arthritis.

Authors:  Adam Young; Gouri Koduri
Journal:  Best Pract Res Clin Rheumatol       Date:  2007-10       Impact factor: 4.098

Review 7.  Treatment strategies for a rheumatoid arthritis patient with interstitial lung disease.

Authors:  Clive Kelly; Vadivelu Saravanan
Journal:  Expert Opin Pharmacother       Date:  2008-12       Impact factor: 3.889

8.  Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease.

Authors:  Lisa Harlow; Ivan O Rosas; Bernadette R Gochuico; Ted R Mikuls; Paul F Dellaripa; Chester V Oddis; Dana P Ascherman
Journal:  Arthritis Rheum       Date:  2013-04

9.  Rheumatoid lung disease.

Authors:  Kevin K Brown
Journal:  Proc Am Thorac Soc       Date:  2007-08-15

Review 10.  Epidemiology of extra-articular manifestations in rheumatoid arthritis.

Authors:  C Turesson; L T H Jacobsson
Journal:  Scand J Rheumatol       Date:  2004       Impact factor: 3.641

View more
  10 in total

Review 1.  Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: Shared Mechanistic and Phenotypic Traits Suggest Overlapping Disease Mechanisms.

Authors:  Francisco Paulin; Tracy J Doyle; Elaine A Fletcher; Dana P Ascherman; Ivan O Rosas
Journal:  Rev Invest Clin       Date:  2015 Sep-Oct       Impact factor: 1.451

2.  Extensive Citrullination Promotes Immunogenicity of HSP90 through Protein Unfolding and Exposure of Cryptic Epitopes.

Authors:  Timothy S Travers; Lisa Harlow; Ivan O Rosas; Bernadette R Gochuico; Ted R Mikuls; Sanjoy K Bhattacharya; Carlos J Camacho; Dana P Ascherman
Journal:  J Immunol       Date:  2016-07-22       Impact factor: 5.422

Review 3.  Rheumatoid Arthritis-Associated Interstitial Lung Disease: Current Concepts.

Authors:  Yoel Brito; Marilyn K Glassberg; Dana P Ascherman
Journal:  Curr Rheumatol Rep       Date:  2017-11-09       Impact factor: 4.592

4.  IgA Antibodies Directed Against Citrullinated Protein Antigens Are Elevated in Patients With Idiopathic Pulmonary Fibrosis.

Authors:  Joshua J Solomon; Scott Matson; Lindsay B Kelmenson; Jonathan H Chung; Stephen B Hobbs; Ivan O Rosas; Paul F Dellaripa; Tracy J Doyle; Sergio Poli; Anthony J Esposito; Ashley Visser; A Itzam Marin; Isabelle Amigues; Evans R Fernández Pérez; Kevin K Brown; Michael Mahler; David Heinz; Carlyne Cool; Kevin D Deane; Jeffrey J Swigris; M Kristen Demoruelle
Journal:  Chest       Date:  2019-12-23       Impact factor: 10.262

5.  Current Perspectives On Emerging Biomarkers For Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Authors:  Isabelle Amigues; Deepa Ramadurai; Jeffrey J Swigris
Journal:  Open Access Rheumatol       Date:  2019-10-15

Review 6.  Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment.

Authors:  George E Fragoulis; Elena Nikiphorou; Jörg Larsen; Peter Korsten; Richard Conway
Journal:  Front Med (Lausanne)       Date:  2019-10-23

7.  Observational studies: Ambient air pollution and hospitalization for RA-ILD in a heavily polluted city in China.

Authors:  Baojin Liu; Guangzhi Sun; Ying Liu; Yanfeng Hou
Journal:  Medicine (Baltimore)       Date:  2022-05-13       Impact factor: 1.817

8.  Cross-Tissue Transcriptomic Analysis Leveraging Machine Learning Approaches Identifies New Biomarkers for Rheumatoid Arthritis.

Authors:  Dmitry Rychkov; Jessica Neely; Tomiko Oskotsky; Steven Yu; Noah Perlmutter; Joanne Nititham; Alexander Carvidi; Melissa Krueger; Andrew Gross; Lindsey A Criswell; Judith F Ashouri; Marina Sirota
Journal:  Front Immunol       Date:  2021-06-08       Impact factor: 8.786

Review 9.  Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows.

Authors:  Giulia Cassone; Andreina Manfredi; Caterina Vacchi; Fabrizio Luppi; Francesca Coppi; Carlo Salvarani; Marco Sebastiani
Journal:  J Clin Med       Date:  2020-04-10       Impact factor: 4.241

10.  Risk Factors and Changes of Peripheral NK and T Cells in Pulmonary Interstitial Fibrosis of Patients with Rheumatoid Arthritis.

Authors:  Na-Lin Lai; Wen Jia; Xia Wang; Jing Luo; Guang-Ying Liu; Chong Gao; Xiao-Feng Li; Jian-Fang Xie
Journal:  Can Respir J       Date:  2019-12-01       Impact factor: 2.409

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.